ClinicalTrials.gov
public full text
Public Domain
Clinical Research of H3F3AK27M in Spinal Glioma and Its Impact on TMZ Chemoradiotherapy
H3F3AK27M may be a feature of primary spinal cord glioma and affect the outcome and prognosis of TMZ chemoradiotherapy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer#1245801
- Virotherapy for Spinal and Spinal Cord Tumors: Current Evidence and Future Perspectives#1267708
- Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)#1310228
- 3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)#800358
- Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer#1087066
Record · ID 1410360
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive